2006 Biotechnology Heritage Award Announced
The Chemical Heritage Foundation and the Biotechnology Industry Organization presented the 8th Annual Biotechnology Heritage Award to Alejandro Zaffaroni, PhD, a biotechnology pioneer and entrepreneur. The award was presented on April 10 at BIO 2006 in Chicago.
The Chemical Heritage Foundation and the Biotechnology Industry Organization (BIO, Washington, DC, www.bio.org) presented the 8th Annual Biotechnology Heritage Award to Alejandro Zaffaroni, PhD, a biotechnology pioneer and entrepreneur. The award was presented on April 10 at BIO 2006 in Chicago. "Dr. Zaffaroni's scientific contributions, particularly in the area of drug delivery, have enhanced healthcare for people throughout the world," said BIO President Jim Greenwood.
Zaffaroni developed and patented several transdermal, controlled-release drug delivery methods and founded ALZA Corporation (Mountain View, CA, www.alza.com) to bring this technology to the world market. Early in his career, Zaffaroni helped transform Syntex (Mexico City, Mexico), a small chemical company, into a major pharmaceutical company that pioneered the development of oral contraceptive pills. He later founded companies such as DNAX, Affymax, and Affymetrix to that developed medical and pharmaceutical products.
In 1995, President Bill Clinton awarded Zaffaroni the National Medal of Technology in recognition of his contributions to the pharmaceutical and biotechnology industries. He became the first recipient of the Lifetime Achievement Award of the University of California at Berkeley Entrepreneurs Forum in 1998 and was elected fellow of the American Association for the Advancement of Science.
Hesperos, Psilera Agree to Accelerate Organ-on-a-Chip Treatment for Frontotemporal Dementia
June 9th 2025The partnership leverages the Hesperos organ-on-a-chip platform in the preclinical development of Psilera’s lead compound targeting the progressive neurological disorder for which treatment options are few.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
How Smart Technology is Helping Reach Sustainability Goals in Drug Packaging
June 7th 2025Smart technologies, such as digital and laser printing, incorporated into manufacturing equipment are helping manufacturers align with sustainability goals, according to Sheikh Akbar Ali, general manager and head of Development and Technology for ACG Packaging Materials.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Market Demands and Emerging Technologies Shape Outsourcing Models
June 5th 2025Trends in certain forms of drug delivery, as well as the emergence of artificial intelligence, are playing roles in evolving the nature of partnerships, but there are new types of partnerships gaining steam as well.
